DEVX vs SICAGEN: Stock Comparison

DEV ACCELERATOR vs SICAGEN INDIAUpdated 15 Sept 26, 1:56 PM ISTNSE & company filings

DEV ACCELERATOR is the larger company by market capitalisation. DEV ACCELERATOR shows a higher ROE, faster revenue growth and a higher ROCE, while SICAGEN INDIA shows a lower P/E, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

DEVX leads 7; SICAGEN leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

DEVXSICAGEN

Valuation lens

What price are you paying?

Market CapContext only
₹317 Cr
₹221 Cr
P/E RatioSICAGEN has the lower reading
29.78x
11.41x
P/B RatioSICAGEN has the lower reading
1.62x
0.47x
EPSSICAGEN has the higher reading
₹1.26
₹1.75
Book ValueContext only
₹17.12
₹125.09
Dividend YieldSICAGEN has the higher reading
0%
3.74%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
DEVX is the larger company
₹317 Cr vs ₹221 Cr
P/E Ratio
SICAGEN has a lower P/E
11.41x vs 29.78x
P/B Ratio
SICAGEN has a lower P/B
0.47x vs 1.62x
EPS
SICAGEN has higher earnings per share
₹1.75 vs ₹1.26
Dividend Yield
SICAGEN has a higher dividend yield
3.74% vs 0%
Revenue Growth (TTM YoY)
DEVX has faster revenue growth
19.1% vs 0%
EPS Growth (TTM YoY)
DEVX has faster EPS growth
631.9% vs 0%
Qtr Sales Growth
SICAGEN has stronger quarterly sales growth
115.12% vs -21.92%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricDEVXSICAGEN
SectorServices
IndustryDiversified Commercial Services

Price

MetricDEVXSICAGEN
Live Price₹33.3₹53.53
Day Change-2.2%0%
Volume28,53111,253
52-Week High₹54₹74.06
52-Week Low₹29.95₹46.55
Distance from 52W High-38.33%-27.72%

Valuation

MetricDEVXSICAGEN
Market Cap₹317 Cr₹221 Cr
P/E Ratio29.78x11.41x
P/B Ratio1.62x0.47x
EPS₹1.26₹1.75
Book Value₹17.12₹125.09
Dividend Yield0%3.74%

Growth

MetricDEVXSICAGEN
Revenue Growth (TTM YoY)19.1%0%
EPS Growth (TTM YoY)631.9%0%
Qtr Sales Growth-21.92%115.12%
Qtr Profit Growth33.22%26.46%

Profitability & Leverage

MetricDEVXSICAGEN
ROE4.76%3.07%
ROCE14.79%4.15%
Net Margin4.57%1.86%
Operating Margin26.66%4.48%
Debt to Equity0.78x0.13x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricDEVXSICAGEN
Promoter Holding35.09% 1.72 pp23.92%
FII Holding1.36% 0.07 pp2.47%
DII Holding3.93% 1.01 pp0.58%
Public Holding59.63% 2.81 pp35.81%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: DEV ACCELERATOR and SICAGEN INDIA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.